Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

An array of problems

Despite the huge amount of published microarray data in cancer, little is being converted into clinical practice. Validating initial data is proving to be a key challenge.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Michiels, S. et al. Lancet 365, 488–492 (2005).

    Article  CAS  Google Scholar 

  2. Ioannidis, J. P. A. Lancet 365, 454–455 (2005).

    Article  Google Scholar 

  3. van't Veer, L. et al. Nature 415, 530–535 (2002).

    Article  CAS  Google Scholar 

  4. van de Vijver, M. J. et al. New Engl. J. Med. 347 1999–2009 (2002).

    Article  CAS  Google Scholar 

  5. Bhattacharjee, A. et al. Proc. Natl Acad. Sci. USA 98, 13790–13795 (2001).

    Article  CAS  Google Scholar 

  6. Garber, M. E. et al. Proc. Natl Acad. Sci. USA 98, 13784–13789 (2001)

    Article  CAS  Google Scholar 

  7. Beer, D. G. et al. Nature Med. 8, 816–824 (2002).

    Article  CAS  Google Scholar 

  8. Dobbin, K. K. et al. Clin. Cancer Res. 11, 565–572 (2005).

    CAS  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frantz, S. An array of problems. Nat Rev Drug Discov 4, 362–363 (2005). https://doi.org/10.1038/nrd1746

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd1746

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing